Skip to Main Content

Paper Details

Fragmentomic analysis of circulating tumor DNA-targeted cancer panels.
Ann Oncol
3
2023
breast, lung, and prostate cancers, breast, lung, prostate, bladder cancers, cancer, cell, cell-free DNA, cfDNA, circulating tumor DNA, ctDNA, first coding exon, non, non-cancer, patients, targeted cancer gene, tumor
Author NameAffiliation
Matti AnnalaUniversity of British Columbia, Canada Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Martin Sj??str??mUniversity of California San Francisco, San Francisco Helen Diller Family Comprehensive Cancer Center
David A QuigleyHelen Diller Family Comprehensive Cancer Center, University of California San Francisco
Himisha BeltranLank Center for Genitourinary Oncology, Dana-Farber Cancer Institute
Himisha BeltranLank Center for Genitourinary Oncology, Dana-Farber Cancer Institute
Felix Y FengUniversity of California San Francisco, San Francisco Helen Diller Family Comprehensive Cancer Center, University of Minnesota
Ruth M O'ReganCarbone Cancer Center, University of Wisconsin, University of Rochester
Alexander W WyattUniversity of British Columbia
Joshua M LangCarbone Cancer Center, University of Wisconsin
  • 1 - 9

Datasets

Release 1.2